Bravelle (Ferring Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Bravelle drug offered from Ferring Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ferring Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Urofollitropin |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-05-06 |
END MARKETING DATE: | 0000-00-00 |
Bravelle HUMAN PRESCRIPTION DRUG Details:
Item Description | Bravelle from Ferring Pharmaceuticals Inc. |
LABELER NAME: | Ferring Pharmaceuticals Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2002-05-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55566-8505_af590fbf-a3fd-4b69-986b-186f8ac242bd |
PRODUCT NDC: | 55566-8505 |
APPLICATION NUMBER: | NDA021289 |